On November 9, ISDA sent a paper to the European Commission and UK Financial Conduct Authority recommending that over-the-counter (OTC) derivatives are identified using unique product identifiers (UPIs) for EU and UK transparency requirements, augmented with some key trade-level attributes (known as UPI+). ISDA believes this would be more appropriate than ISINs because it would enable users to aggregate and perform meaningful analysis on instrument pricing across the market. These additional attributes would ensure OTC derivatives could be identified and aggregated in a way that is useful to market participants while providing sufficient granularity to distinguish between different products.
Documents (1) for ISDA Paper on Unique Product Identifiers
Latest
Joint Response on Future of Tokenization
On July 6, ISDA and Global Digital Finance (GDF) submitted a joint response to a call for input on the future of tokenization by the Financial Conduct Authority (FCA) and Bank of England. Tokenization presents a significant opportunity for the...
ISDA In Review – June 2026
A compendium of links to new documents, research papers, press releases and comment letters published by ISDA in June 2026.
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
Letter on EU Legislative Reform
On July 1, ISDA and 11 other trade associations published a statement on enhancing the EU legislative and supervisory framework to support market competitiveness. The statement highlights a significant opportunity to strengthen the EU’s regulatory and supervisory framework through the...